methylthio-adp has been researched along with propranolol in 1 studies
| Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
|---|---|---|---|---|---|
| 146 | 2 | 43 | 33,310 | 3,406 | 3,218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erlinge, D; Götberg, M; Olivecrona, G; Olsson, ML; Wang, L; Winzell, MS | 1 |
1 other study(ies) available for methylthio-adp and propranolol
| Article | Year |
|---|---|
ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Apyrase; Cyclic AMP; Epinephrine; Erythrocyte Membrane; Erythrocytes; Feedback, Physiological; Female; Humans; Male; Microdialysis; Phentolamine; Propranolol; Receptors, Purinergic P2; Reticulocytes; RNA, Messenger; Sus scrofa; Thionucleotides | 2005 |